Paper17568824
Management of chronic hepatitis C: consensus guidelines.
Sherman M and 9 others. Can J Gastroenterol, 2007. Cited by 83 papers, by iCite.
Cite this record
ConductScience Library. Management of chronic hepatitis C: consensus guidelines. Papers, record 17568824. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17568824
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Hepatitis C | Major topic |
| Canada | |
| Humans |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01095445 | EXtended Therapy in Hepatitis C Genotype 3 Infected Patients | Background |
Source ClinicalTrials.gov
References89
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17033526 | Safety, efficacy and pharmacokinetics of peginterferon alpha2a (40 kd) in children with chronic hepatitis C. | J Pediatr Gastroenterol Nutr | 2006 | https://conductscience.org/library/papers/17033526 | PubMed |
| 2 | 16767309 | Peginterferon alfa-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy. | Braz J Infect Dis | 2006 | https://conductscience.org/library/papers/16767309 | PubMed |
| 3 | 15940780 | Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus. | J Rheumatol | 2005 | https://conductscience.org/library/papers/15940780 | PubMed |
| 4 | 16234288 | Randomized trial of pegylated interferon alpha-2b monotherapy in haemodialysis patients with chronic hepatitis C. | Nephrol Dial Transplant | 2006 | https://conductscience.org/library/papers/16234288 | PubMed |
| 5 | 12407571 | National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002. | Hepatology | 2002 | https://conductscience.org/library/papers/12407571 | PubMed |
| 6 | 15558712 | Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study. | Hepatology | 2004 | https://conductscience.org/library/papers/15558712 | PubMed |
| 7 | 7698595 | American Gastroenterological Association Medical Position Statement: guidelines for the use of enteral nutrition. | Gastroenterology | 1995 | https://conductscience.org/library/papers/7698595 | PubMed |
| 8 | 11848726 | Surprisingly small effect of antiviral treatment in patients with hepatitis C. | Ann Intern Med | 2002 | https://conductscience.org/library/papers/11848726 | PubMed |
| 9 | 15751068 | PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. | Arthritis Rheum | 2005 | https://conductscience.org/library/papers/15751068 | PubMed |
| 10 | 15768339 | Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users. | Clin Infect Dis | 2005 | https://conductscience.org/library/papers/15768339 | PubMed |
| 11 | 12962779 | Outcome of kidney transplant in chronic hepatitis C virus patients: effect of pretransplantation interferon-alpha2b monotherapy. | Transplant Proc | 2003 | https://conductscience.org/library/papers/12962779 | PubMed |
| 12 | 15273266 | Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada. | J Urban Health | 2004 | https://conductscience.org/library/papers/15273266 | PubMed |
| 13 | 15972867 | Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15972867 | PubMed |
| 14 | 16709661 | Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy. | Gut | 2006 | https://conductscience.org/library/papers/16709661 | PubMed |
| 15 | 15239094 | A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance. | Hepatology | 2004 | https://conductscience.org/library/papers/15239094 | PubMed |
| 16 | 16025497 | Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. | Hepatology | 2005 | https://conductscience.org/library/papers/16025497 | PubMed |
| 17 | 16530503 | Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response. | Gastroenterology | 2006 | https://conductscience.org/library/papers/16530503 | PubMed |
| 18 | 16630037 | Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV-coinfected individuals. | HIV Med | 2006 | https://conductscience.org/library/papers/16630037 | PubMed |
| 19 | 17162319 | Infection rates in HIV-HCV patients treated with interferon are similar to those in HCV mono-infection and not related to neutropenia. | HIV Clin Trials | 2006 | https://conductscience.org/library/papers/17162319 | PubMed |
| 20 | 15826710 | Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. | J Hepatol | 2005 | https://conductscience.org/library/papers/15826710 | PubMed |
Cited by54
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42872224 | Trends in chronic hepatitis C visits by providers in Quebec, Canada: A population-level cohort study. | Can Liver J | 2026 | https://conductscience.org/library/papers/42872224 | PubMed |
| 37040993 | Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study. | CMAJ | 2023 | https://conductscience.org/library/papers/37040993 | PubMed |
| 35989890 | Characterizing risk behaviour and reinfection rates for successful programs to engage core transmitters in HCV elimination (C-RESPECT). | Can Liver J | 2021 | https://conductscience.org/library/papers/35989890 | PubMed |
| 35787600 | A Real-World Study to Compare the Safety and Efficacy of Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir, with or without Ribavirin, in 587 Patients with Chronic Hepatitis C at the Fundeni Clinical Institute, Bucharest, Romania. | Med Sci Monit | 2022 | https://conductscience.org/library/papers/35787600 | PubMed |
| 33173710 | Assessing State Variation in Plastic Surgeons' Risk of Hepatitis C Exposure: Revisit in Methodology. | Plast Reconstr Surg Glob Open | 2020 | https://conductscience.org/library/papers/33173710 | PubMed |
| 30705482 | Prevalence and genotyping pattern of hepatitis C virus among patients on maintenance hemodialysis at five centers in Pune, India. | Med J Armed Forces India | 2019 | https://conductscience.org/library/papers/30705482 | PubMed |
| 29769873 | Hepatitis C surveillance in Canada. | Can Commun Dis Rep | 2014 | https://conductscience.org/library/papers/29769873 | PubMed |
| 29557047 | Let's Talk About B: Barriers to Hepatitis B Screening and Vaccination Among Asian and South Asian Immigrants in British Columbia. | J Racial Ethn Health Disparities | 2018 | https://conductscience.org/library/papers/29557047 | PubMed |
| 26851949 | Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies. | Eur J Clin Microbiol Infect Dis | 2016 | https://conductscience.org/library/papers/26851949 | PubMed |
| 25583667 | Cost-effectiveness of screening for hepatitis C in Canada. | CMAJ | 2015 | https://conductscience.org/library/papers/25583667 | PubMed |
| 25278674 | Eligibility of persons who inject drugs for treatment of hepatitis C virus infection. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/25278674 | PubMed |
| 24948971 | Association of Hepatitis C Virus Infection and Interleukin-28B Gene Polymorphism in Chinese Children. | Pak J Med Sci | 2014 | https://conductscience.org/library/papers/24948971 | PubMed |
| 24782620 | Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/24782620 | PubMed |
| 24696622 | The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia. | Hepat Med | 2013 | https://conductscience.org/library/papers/24696622 | PubMed |
| 24212914 | Chronic hepatitis C in Western Canada: a survey of practice patterns among gastroenterologists in Alberta and British Columbia. | Can J Gastroenterol Hepatol | 2014 | https://conductscience.org/library/papers/24212914 | PubMed |
| 24205255 | Hepatitis B screening and vaccination strategies for newly arrived adult Canadian immigrants and refugees: a cost-effectiveness analysis. | PLoS One | 2013 | https://conductscience.org/library/papers/24205255 | PubMed |
| 23781516 | The epidemiology of hepatitis C in a Canadian Indigenous population. | Can J Gastroenterol | 2013 | https://conductscience.org/library/papers/23781516 | PubMed |
| 23714158 | The metabolomic window into hepatobiliary disease. | J Hepatol | 2013 | https://conductscience.org/library/papers/23714158 | PubMed |
| 23517633 | Hepatitis C and the surgeon. | Can J Surg | 2013 | https://conductscience.org/library/papers/23517633 | PubMed |
| 23509527 | Pharmacists and harm reduction: A review of current practices and attitudes. | Can Pharm J (Ott) | 2012 | https://conductscience.org/library/papers/23509527 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17568824
GET https://conductscience.org/api/papers/v1/17568824/references?page=2